Author

P. Rameshwar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Chemerinski· 1 shared A. Lemenze· 1 shared A. Lipton· 1 shared A. M. Paul· 1 shared B. George· 1 shared G. N. Hortobagyi· 1 shared K. Larios· 1 shared K. Leitzel· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Chemerinski

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Bone Marrow- and Umbilical Cord-Derived Mesenchymal Stem Cell Secretome Alters Gene Expression and Upregulates Motility of Human Endometrial Stromal Cells

Q. Zhao, K. Larios, Y. Naaldijk, L. Sherman, A. Chemerinski, K. Okereke, P. Rameshwar, A. Lemenze, N. C. Douglas, S. S. Morelli

This study shows that MSC secretomes from bone marrow and umbilical cord increase endometrial stromal cell motility via upregulated CCL2 expression.

bioRxiv · Nov 12, 2022 · PreprintCell Biology

Cellular Fitness Phenotypes of Cancer Target Genes from Oncobiology to Cancer Therapeutics

B. George, A. M. Paul, P. P. Mukundan, R. Amjesh, K. Leitzel, S. M. Ali, O. Sandiford, A. Lipton, P. Rameshwar, G. N. Hortobagyi, R. M. Pillai, R. Kumar

The paper examines fitness dependencies of cancer drug targets across 19 cancer types, finding that some targets are not fitness genes and suggesting drug repurposing opportunities.

bioRxiv · Jan 28, 2021 · PreprintCancer Biology

Exosome-mediated hematopoietic rejuvenation in a humanized mouse model indicate potential for cancer immunotherapy

The paper shows exosome-mediated hematopoietic rejuvenation in a humanized mouse model can enhance immune function and eliminate dormant cancer cells.

bioRxiv · Aug 2, 2020Cell Biology